Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study

Fig. 1

Study design overview (created with BioRender.com). CAD, coronary artery disease; CKD, chronic kidney disease; CNP, C-type natriuretic peptide; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; IVW-MR, inverse variance weighted mendelian randomization; LDL-C, low-density lipoprotein cholesterol; NPR2, natriuretic peptide receptor 2; NPR3, natriuretic peptide receptor 3; SBP, systolic blood pressure; T2DM, Type-2 diabetes mellitus; TG, triglycerides

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us